• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELSOFT; GELSOFT DOUBLE BIFURCATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELSOFT; GELSOFT DOUBLE BIFURCATE Back to Search Results
Model Number GELSOFT DOUBLE BIFURCATE
Device Problem Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/25/2021
Event Type  malfunction  
Manufacturer Narrative
The site advised that the device is not available; therefore no evaluation of the graft was possible.(b)(4).Review of similar complaints of leakage for all gelsoft branded devices gave an occurrence rate of b4.Additional information was requested from the clinician regarding the procedure.A review of the retained qc and manufacturing records for this batch (with attention to all in process and base material porosity testing) confirmed that the batch was manufactured to its design specification.The site advised that the device is not available.No issue was found with the manufacturing of the batch (based on the review of the retained production records).The root cause of the reported defect could not be determined.Vascutek ltd.Considers this event as closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process, if an adverse trend develops action may be taken at that time.
 
Event Description
Vascutek ltd.S (b)(4) distribution partner ((b)(4)) reported an incidence of blood leakage of a gelsoft bifurcate graft.The graft was originally implanted on (b)(6) 2019.The patient underwent a laparotomy procedure on (b)(6) 2021 for the removal of a pseudo aneurysm; it was noted after the removal of the aneurysm blood leakage was observed from the in-situ gelsoft graft.The event was reported to vascutek ltd.As possibly device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSOFT
Type of Device
GELSOFT DOUBLE BIFURCATE
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
renfrewshire, PA4 9-RR
UK   PA4 9RR
MDR Report Key11471915
MDR Text Key246050203
Report Number9612515-2021-00009
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881110011
UDI-Public05037881110011
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P890045/S1
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 03/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/12/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model NumberGELSOFT DOUBLE BIFURCATE
Device Catalogue Number631809DB
Device Lot Number17705600
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-